HDL Therapeutics Competitors and Similar CompaniesClear all
HDL Therapeutics's competitors and similar companies include ElectroCore and FIRE1.
 HDL Therapeutics HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis. |  ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | ||
Founding Date | Founding Date 2009 | Founding Date 2005 | Founding Date N/A |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Vero Beach, US HQ | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US | Locations Dublin, IE HQ Dublin, IE |
Employees | Employees 7 | Employees 5144% decrease | Employees 838% increase |
Funding | |||
Latest funding round | Latest funding round $ 3m (almost 7 years ago) | Latest funding round N/A | Latest funding round $ 7.5m (about 10 years ago) |
Total funding raised | Total funding raised $ 7.4m | Total funding raised $ 127m | Total funding raised $ 7.5m |
For sources of this data, please see the company profile
View Company Profiles
ElectroCore
HQ
Rockaway, US
Employees
51↓ 44% decrease
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
View company
FIRE1
HQ
Dublin, IE
Employees
83↑ 8% increase
FIRE1 focuses on developing novel remote monitoring devices.
View company